Tissue Inhibitor of Metalloproteinase (TIMP)-2 Acts Synergistically with Synthetic Matrix Metalloproteinase (MMP) Inhibitors but Not with TIMP-4 to Enhance the (Membrane Type 1)-MMP-dependent Activation of Pro-MMP-2

This publication has 64 references indexed in Scilit:

• Inactivating Mutation of the Mouse Tissue Inhibitor of Metalloproteinases-2(Timp-2) Gene Alters ProMMP-2 Activation
  Journal of Biological Chemistry, 2000
• TIMP-2 Is Required for Efficient Activation of proMMP-2 in Vivo
  Journal of Biological Chemistry, 2000
• Potent and Selective Mechanism-Based Inhibition of Gelatinases
  Journal of the American Chemical Society, 2000
• Biophysical and Functional Characterization of Full-length, Recombinant Human Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Produced in Escherichia coli
  Journal of Biological Chemistry, 1999
• MMP-2 and TIMP-2 Expression Correlates with Poor Prognosis in Cervical Carcinoma—A Clinicopathologic Study Using Immunohistochemistry and mRNA in Situ Hybridization
  Gynecologic Oncology, 1999
• Membrane-type matrix metalloproteinase-1(MT1-MMP) gene is overexpressed in highly invasive hepatocellular carcinomas
  Journal of Hepatology, 1998
• Matrix Metalloproteinases
  Drugs & Aging, 1997
• The recombinant catalytic domain of membrane‐type matrix metalloproteinase‐1 (MT1‐MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP‐2
  FEBS Letters, 1996
• The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation
  Journal of Biological Chemistry, 1996
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970